Showing results (161-170 of 302) with videos related to
Sort By:
Pageof 31
Cancer|June 23, 2007
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinomaAndrew X Zhu, Keith Stuart, Lawrence S Blaszkowsky, et al.Journal of Gastrointestinal Oncology|January 24, 2022
Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case reportDouglas Rubinson, Brian M Wolpin, Ilana S Warsofsky, et al.Cancer Chemotherapy and Pharmacology|October 3, 2002
Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicityThomas A Puchalski, David P Ryan, Rocio Garcia-Carbonero, et al.The Oncologist|June 1, 2017
Predictors of Disruptions in Breast Cancer Care for Individuals with SchizophreniaKelly E Irwin, Elyse R Park, Jennifer A Shin, et al.The Journal of Clinical Investigation|October 12, 2011
Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancersHiromichi Ebi, Ryan B Corcoran, Anurag Singh, et al.Practical Radiation Oncology|May 3, 2017
Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiationBrent Rose, Devarati Mitra, Theodore S Hong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Activity of sunitinib in patients with advanced neuroendocrine tumorsMatthew H Kulke, Heinz-Josef Lenz, Neal J Meropol, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumorsCasey Cunningham, Leonard J Appleman, Miora Kirvan-Visovatti, et al.The British Journal of Radiology|June 15, 2017
Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant diseaseAmar U Kishan, Justin C Voog, Jonathan Wiseman, et al.American Journal of Clinical Oncology|October 15, 2016
Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic AdenocarcinomaFlorence K Keane, Jennifer Y Wo, Cristina R Ferrone, et al.Pageof 31